Use of BTG-1604 pharmaceutical preparation for prevention of post-transplant lung injury (IPS and obliterative bronchiolitis) in a murine model
|Effective start/end date||5/23/13 → 5/22/14|
- BTG INTERNATIONAL INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.